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EDITORIAL
Expanding antiretroviral therapy provision in resource-constrained settings: social processes and
their policy challenges
The international policy and research context
Political pressure to provide antiretroviral therapy
(ART) in poor countries, alongside falling drug
prices, led to a dramatic increase in ART delivery
from 2002. In that year the Global Fund for AIDS,
TB and Malaria was established. In 2003, President
George W. Bush pledged US$15 billion towards his
Presidential Emergency Programme for AIDS Relief
(PEPFAR) and the World Health Organisation
(WHO) launched the ‘‘35’’ campaign aiming to
place three million people on treatment by 2005.
Although the WHO goal was not achieved, the
investment meant by the end of 2008 about four
million people in low- and middle-income countries
were receiving ART.
Research to inform and evaluate ART expansion
in resource-constrained settings has, perhaps inevita-
bly, focused on the impact of different drug combina-
tions and clinical outcomes, related public health
questions, and on the effectiveness and costs of
different modes of delivery. Social or behavioural
science research has tended to focus on the important
question of patient adherence. Social research has
recently started to explore the effects of ART on
stigma, sexual relationships, new identities, political
activism, and the inequalities that underlie HIV-
infection and undermine ART delivery (Bunnell
et al., 2006; Castro & Farmer, 2005; Domek, 2006;
Robins, 2005; Seeley et al., 2009, for example).
However, research about the social processes unfold-
ing as a result of ART has been relatively rare
(Russell et al., 2007). As social scientists, we expect
the provision of an effective drug for a previously
terminal, feared and highly stigmatised disease to
have profound implications and meanings for social
and economic aspects of life; for individuals, families,
communities and health services, and for wider social
norms, expectations and behaviours. These unfolding
social changes will affect society, but also specifically
ART programme processes and outcomes, for exam-
ple, reductions in stigma and increasing numbers of
support groups can speed up uptake and increase
adherence.
In this special edition we consider several broad
areas of enquiry. How is ART affecting the social
construction of the disease, people’s identities and
stigma? How are people adjusting to a new chance of
life, to living with HIV as a chronic condition, and
what challenges do they face in rebuilding their social
and economic lives as they return to the harsh
realities of poverty? How is ART delivery affecting
the working and personal lives of health workers and
what are the implications for health systems?
This issue presents papers presented at a con-
ference: Expanding antiretroviral therapy provision in
resource-limited settings: social dynamics and policy
challenges, held in May 2009 at the University of East
Anglia (UEA), UK. The conference was organised by
the School of International Development, UEA, and
the Health Economics and HIV/AIDS Research
Division (HEARD) of University of KwaZulu-Natal.
It brought together international research organisa-
tions and partnerships to share original social science
research on ART delivery and its effects in resource-
constrained settings. This is one of the first collections
of social research on patients’ and health workers’
responses to ART and its effects on their lives and
livelihoods.
Summary of themes and papers
The diverse topics covered by these papers follow a
broad analytical theme of social actions and processes
surrounding ART delivery and uptake, and their (often
unintended) implications for policy. The papers exam-
ine social actors and processes from the perspective of
those accessing and taking the treatment, often
people coming back from near-biological and social
death and striving to build a new life on ART, and
those delivering or funding ART interventions. They
are organised into three themes: ART and changing
identities; ART and living with HIV; and ART and
its effects for health services.
ART and changing identities
ART provides effective treatment for a previously
untreatable and terminal disease. It leads to improved
health and enables a return to normal activities.
These social facts could have profound implications
for the way a society applies meaning to and ‘‘socially
constructs’’ the disease and labels or categorises those
people with that disease. Across societies, HIV has
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been characterised by high levels of stigma and
discrimination. While stigma must be conceptualised
as a social process arising from structural inequalities
and the exertion of power and control (Castro &
Farmer, 2005; Parker & Aggleton, 2003), the nature
of the disease itself makes it open to social processes
of labelling and the categorisation of ‘‘undesirable’’
or ‘‘undeserving’’ ‘‘others’’. In most societies’ moral
frameworks it is associated with perceived ‘‘deviant’’
or ‘‘immoral’’ behaviour and groups; it is seen as the
responsibility of the individual; it is contagious and a
threat to the community; it was the equivalent of
a death sentence with no treatment; and death was
slow and painful (Alonzo & Reynolds, 1995). ART
cannot necessarily address the structural inequalities
or moral frameworks that drive processes of stigma-
tisation and discrimination, but does offer a chance
to counteract some of the above processes through
prolonged life and improved health and appearance.
The papers on this theme consider ART’s
implications for the social construction of the disease
and the identity of those people living with HIV
(PLHIV). Does ART necessarily reduce people’s fear
of getting tested or disclosing their status and reduce
the stigma? How have political struggles for treat-
ment affected identity and the place of PLHIV in
public health discourse? Does a ‘‘medicalisation’’ of
HIV through ART offer new opportunities for HIV
organisations to link up with communities in the
‘‘fight against HIV’’?
Virginia Bond draws on 20 years of living and
working in a high HIV prevalence country, Zambia,
to explore the reasons that lie behind people’s limited
uptake of HIV testing or public disclosure of their
status, despite increased availability of ART since
2004. She describes how PLHIV must carefully
negotiate the pragmatic advantages of testing and
disclosing alongside the fear of the result and a
permanent shift to their identity following disclosure.
When it is spoken, Bond argues, the ‘‘possibility’’ of
infection, the ‘‘implicit knowing’’ of others becomes
reality and a person’s HIV status becomes a promi-
nent and fixed identity. Disclosure is a complex
matter, taking many forms and often a gradual and
careful process to a limited circle. Silence is often an
easier option, perhaps with the presence of HIV
implicitly known but not spoken. Better understand-
ing of disclosure processes is needed to inform safe
disclosure procedures in the VCT and ART pro-
grammes being rolled out in Sub-Saharan Africa.
Bernays, Rhodes and Terz´ic´ present qualitative
findings from Serbia to look at the effects of
treatment on stigma. Their analysis reveals that
structural factors continue to make HIV a stigma-
tised disease despite the availability of ART. Here,
HIV affects mainly marginal and stigmatised groups
(sex workers, gay men and drug-users). Public
resource constraints mean moral-economic judge-
ments construct ART as a diverter of scarce funds
away from more ‘‘socially deserving’’ conditions.
Structural obstacles to finding work add to feelings
of disempowerment and dependency. HIV and ART
are cast as threats to both the social and economic
fabric of the country. They conclude that HIV
treatment is insufficient alone to reduce stigma and
needs to be supported by complementary employ-
ment and social support interventions enabling
PLHIV to lead more empowered economic and social
lives.
Kielmann and Cataldo examine how collective
action around access to ART, involving political
claims for social justice, human rights and health
care, have forged new individual and group identities
among PLHIV. Associated processes have con-
structed them as ‘‘expert’’ patients and ‘‘empowered
citizens’’, important actors at the inter-section of
health services and communities. They argue that
constructions of PLHIV as ‘‘responsible patients and
public health citizens’’ are key but may not be
applicable in all treatment settings, and the involve-
ment of patients in health systems raises further
ethical, political and policy questions.
Busher explores how ART delivery expansion in
north-east Namibia is changing the way HIV orga-
nisations and programmes are perceived by tradi-
tional leaders and fit within the wider socio-moral
cultural framework. Traditional leaders view inter-
ventions involving discussions of sex and condoms as
a threat to local moral values and social order,
preventing their involvement in these activities.
However, the rapid expansion of ART after 2004
meant the emphasis shifted to advice about accessing
tests and effective treatment. A new set of signs and
meanings about HIV has enabled traditional leaders
to engage with the fight against HIV, without under-
mining their role as cultural guardians.
ART and living with HIV
ART means HIV has become a manageable chronic
condition rather than a terminal illness. The second
theme looks more closely at the effects of this change
for the social and economic lives of individuals and
their families in resource-constrained settings.
Restored health enables people to return to work,
re-engage with family and participate in social
activities. Numerous changes are required in the lives
of PLHIV as they move from a situation of sickness
and social isolation to a second chance at life. There
are challenges to this adjustment, especially in
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settings of poverty and where ART delivery systems
offer varying degrees of support or security (Rhodes,
Bernays, & Terz´ic´, 2009; Russell et al., 2007). Patients
who may have managed to accept their HIV status
must now incorporate the treatment regimen into
their daily lives  for the rest of their life.
When ART became more widely available in
resource-constrained settings there was widespread
concern about adherence levels. A feature of some
ART programmes in Sub-Saharan Africa is the
requirement for patients to choose a treatment
supporter or medicine companion (MC) to improve
adherence. Foster, Nakamanya, Amurwan and col-
leagues report on the characteristics and roles of MCs
chosen for adherence support by Ugandan patients
enrolling on ART. Women were more likely to
choose one of their children and men more likely to
choose their spouse. An important part of the MC
system is that it entails disclosure of one’s HIV status,
which as Bond argues in this edition can pose a
serious dilemma for people wishing to start ART.
Foster and colleagues note that women may have
been less likely to choose husbands as their MC
because they had not yet disclosed their status to the
husband. Such a disclosure can have serious con-
sequences for women in Uganda. These conclusions
echo those of Bond: ART programmes must consider
the pros and cons of the requirement of disclosure
carefully.
Adjustment to living with HIV as a chronic illness
also requires people to make changes in their
economic, social and personal lives. The challenges
of rebuilding a livelihood, relationships and hope
devastated by HIV are considerable, but vitally
important for individual clients and the success of
ART programmes. People need to be leading mean-
ingful economic and social lives to live with and
manage the disease, and more specifically to go on
adhering to ART (Nam et al., 2008). They need to
live with, as well as manage their chronic illness, and
the management will be affected by the ‘‘living with’’
(Strauss, 1990).
Seeley and Russell’s paper explores people’s
efforts to rebuild social relationships and social lives
following a period of profound disruption caused by
HIV. They use the concept of ‘‘transition’’ to explore
people’s narratives of recovery and change on ART,
and the related idea of ‘‘getting back to normal’’.
Transition refers to a person’s adjustment towards
incorporating a chronic illness and treatment regimen
into their lives, their identity and their interactions
with others (Kralik, 2002). They also consider the
transformative effects of HIV and ART, and the idea
of ‘‘rebirth’’, a process whereby the illness is per-
ceived as an opportunity to live a better life, with a
new outlook, new personal aims, new social roles and
a new status (Pierret, 2007; Robins, 2005). The key
policy challenge is to provide support for people
working to restore their social and economic lives, to
accompany the medical intervention.
Chileshe and Bond also explore people’s efforts to
access ART and manage their condition under
conditions of extreme poverty in a rural setting.
They had experienced the long-term economic shock
and impoverishment caused by a prolonged and
serious illness, TB. Subsequent HIV diagnosis and
access to ART was undermined by this pre-existing
poverty. High transport costs to ART clinics, and a
health service system requiring four visits before
being enrolled on ART, posed serious economic
barriers. Stigma, a recurring theme in this special
edition, also presented barriers. The authors argue
programmes delivering ART in poor rural areas need
to consider the impact of transport and food costs on
treatment adherence and appreciate how many poor
households enter the ART programme with already
depleted household resources.
ART and its effects for health services
Large-scale investment in ART delivery expansion in
poor settings has changed the lives of health workers
and generated considerable changes for health ser-
vices. The scale of funding has also affected wider
processes of health policy governance.
Schneider and Lehmann describe the expansion of
lay health workers in the South African health
system, which now outnumber professional nurses.
They consider the implications for the organisation of
the health system and professional relations between
lay workers and health care professionals. Counsel-
ling and home-based care are routine roles for lay
health workers, and they occupy a ‘‘mediating layer’’
between citizens and the formal health and social
welfare systems. While they are essential to the
delivery and functioning of health care, their prolif-
eration has been uncoordinated and unregulated by
the state, causing numerous organisational and hu-
man resource difficulties. The authors argue that
research is needed to understand this complex phe-
nomenon, to inform measures that can better harness
the potential of lay workers.
Namakhoma and colleagues examine the pres-
sures of delivering ART for already over-stretched
health workers in Malawi, and the difficulties faced
by health workers taking ART themselves as they
wrestle with fears of disclosure.
George and colleagues examine the effects of
ART delivery expansion on health workers at two
ART sites in South Africa. Survey results comparing
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ART and non-ART workers show that ART workers
are less likely to regard their workload as heavy, have
higher levels of job satisfaction, lower rates of
sickness absenteeism and see more opportunities for
professional development. This evidence contradicts
that found in Malawi noted above, and many other
studies that show ART scale-up creates additional
burdens and stress for health workers. Qualitative
interviews explored the reasons for these findings and
found that higher satisfaction and morale and lower
stress were related to their ability to bring treatment
and hope to patients, delay deaths due to AIDS, and
better training opportunities. The wider political
context and better resource levels in South Africa
also explain these findings.
Kudale and colleagues examine the ways social
and political actors within the ART delivery setting
affected the evolution of ART delivery systems in two
high prevalence settings in Maharashtra and Andhra
Pradesh in 2005 and 2009. The study goes beyond a
static analysis of resource constraints to consider the
roles of different actors, the wider political context
and questions of leadership and ownership of the
HIV programmes, and how these processes affected
quality of care and patient pathways to accessing
ART. They conclude that the evolution of ART
programmes within local health systems must con-
sider the wider socio-political environment.
Hanefeld moves to the wider shifts in health policy
processes brought about by the advent of support for
ART by PEPFAR and the Global Fund. She explores
the role of these two global organisations in Zambia
and South Africa over the past five years, focusing on
their influence on policy content and the implemen-
tation of ART programmes. Hanefeld highlights their
influence on governance at national and sub-national
level, showing how because of the intervention of
global players the actual implementation of policy
bypasses the state.
The longer term challenge
The social processes examined here that are arising
from the dramatic expansion of ART for PLHIV in
resource-constrained settings point to the need for a
vision for ART scale-up that must be broadened to
go beyond medicine to incorporate complementary
social, economic and health facility interventions that
consider complex questions of identity, stigma reduc-
tion and disclosure requirements, economic and
social measures that support people’s adjustment to
living with HIV as a chronic condition, and measures
that can address the needs of health workers involved
in ART delivery. The sustainability of ART pro-
grammes depends on this broader vision: in the rush
to scale-up ART delivery the important focus on
clinical priorities must not ‘‘over-medicalise’’ the
agenda and forget other notions of well-being.
These social processes must be placed into the
wider context of funding for ART expansion and the
immense challenges to long-term success. First,
treatment coverage needs to expand further. Only
about 40% of those who need treatment in middle-
and low-income countries are getting it. The number
of people needing drugs will continue to rise each
year, and over time people will need more expensive
second-line regimens. Funding is also needed for the
complementary social and economic interventions
discussed in this special edition. A key question for
development agencies also centres on their long-term
obligations to people supported on ART in resource-
poor settings: will ART be guaranteed for life,
regardless of the increased cost of different treatment
regimens required as resistance develops?
Second, against these growing resource demands
is a situation in which current funding for ART
expansion in Africa is time-limited. Long-term fund-
ing commitments for ART had not been embraced
even before the current international economic reces-
sion. Major HIV/AIDS donors may be forced to
reduce their commitments due to acute budget
constraints, and the global economic crisis will also
affect domestic economies and government budget
resources.
Third, even if donor support were guaranteed,
health system weaknesses in many countries raise
concerns about the feasibility of continued ART roll-
out, particularly in rural and unstable areas. The
foundation upon which success depends  the assur-
ance of an uninterrupted, affordable and accessible
supply of medication and care  remains absent in
many countries.
Finally, there is the question of donor depen-
dency. In many countries the provision of treatment
is undertaken by donors and significant numbers of
people’s lives depend on the largesse of decision
makers in Washington, London, Geneva and Paris.
This is a unique situation which needs careful and
immediate attention.
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